More NewsRead More
Ergomed Ups the Ante for CEL-SCI
October 21, 2015
category Business & Professional Services
CEL-SCI Is Granted a New European Patent on Its Phase 3 Investigational Cancer Immunotherapy Multikine
November 18, 2015
CEL-SCI’s Rheumatoid Arthritis Vaccine Selected for Commercialization & Program Niche Analysis Plan by U.S. National Institutes of Health
November 04, 2015
CEL-SCI Reports Record Monthly Patient Enrollment in October for Its Phase 3 Head and Neck Cancer Trial
November 02, 2015
CEL-SCI Prices Public Offering for up to $12 Million
October 23, 2015
CEL-SCI Corporation Releases Letter to Shareholders
October 19, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here